Quoin Pharmaceuticals announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to its lead product QRX003 for treating Peeling Skin Syndrome. This designation offers benefits like scientific advice, fee reductions, and access to EU grants, plus 10 years of market exclusivity in Europe upon approval. QRX003 is also under evaluation for Netherton Syndrome and has received multiple orphan and pediatric designations from US and Japanese regulators. Quoin plans to start the first formal clinical trial for Peeling Skin Syndrome by the end of 2026, marking a significant step for this underserved rare disease.
Quoin Pharmaceuticals' orphan drug designation news is presented with Pluang's health sector market data for context. For readers following health stocks, 98 of 150 US health-sector stocks rose while 44 fell. Notable movers include LQDA at USD 41.31 with a +54.08% change, ABEO at USD 5.00 with a +10.62% change and a typical hold time of 26 days, and BKD at USD 10.87 with a +7.41% change. This data is as of Oct 14, 2026 17:11 WIB.
Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...
nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...
ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...
Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...
Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...
